Literature DB >> 11162493

Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.

P Gupta1, A Singh, V Chauhan, R Bhatnagar.   

Abstract

Anthrax toxin is a complex of protective antigen (PA, 735 aa), lethal factor (LF, 776 aa), and edema factor (EF, 767 aa). PA binds to cell surface receptors and is cleaved by cell surface proteases into PA63, while LF and EF compete for binding to PA63. The PA63-LF/EF complex is internalized into the cytosol and causes different pathogenic responses in animals and cultured cells. 1-300 amino acid residues of LF have been viewed as the region responsible for the high affinity binding of LF to PA. Amino acid analysis of LF and EF revealed a common stretch of 7 amino acids (147VYYEIGK153). In the present study, each amino acid of this stretch was replaced by alanine at a time. Y148A, Y149A, I151A, and K153A mutants were found to be deficient in their ability to lyse J774A.1 cells and their binding ability to PA63 was drastically reduced. We propose that these four amino acids play a crucial role in the process of binding of LF to PA63. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162493     DOI: 10.1006/bbrc.2000.4099

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor.

Authors:  Vibha Chauhan; Rakesh Bhatnagar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Model of the toxic complex of anthrax: responsive conformational changes in both the lethal factor and the protective antigen heptamer.

Authors:  Florence Tama; Gang Ren; Charles L Brooks; Alok K Mitra
Journal:  Protein Sci       Date:  2006-09       Impact factor: 6.725

3.  Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.

Authors:  B M Price; A L Liner; S Park; S H Leppla; A Mateczun; D R Galloway
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen.

Authors:  P Kumar; N Ahuja; R Bhatnagar
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Certhrax toxin, an anthrax-related ADP-ribosyltransferase from Bacillus cereus.

Authors:  Danielle Visschedyk; Amanda Rochon; Wolfram Tempel; Svetoslav Dimov; Hee-Won Park; A Rod Merrill
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

6.  Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination.

Authors:  Sha Cao; Aizhen Guo; Ziduo Liu; Yadi Tan; Gaobing Wu; Chengcai Zhang; Yaxing Zhao; Huanchun Chen
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

Review 7.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

8.  The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.

Authors:  Melissa L Nguyen; Simon Terzyan; Jimmy D Ballard; Judith A James; A Darise Farris
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.